Safety Procedure Pulmonary Artery Denervation in Addition to Pulmonary Vein Isolation Combined With Ganglionated Plexi Ablation in Patients With Persistent Atrial Fibrillation and Pulmonary Hypertension
Patients with symptomatic, drug - refractory AF ( inefficiency 1C or III Class antiarrhythmic drugs), history of AF 6 months or more without the restoration of sinus rhythm.
MPAP ≥25 mmHg
PCWP≥15 mmHg
Pulmonary vascular resistance (PVR). The PVR =(mPAP-PCWP)/ carbon monoxide\] \> 2.5 woods unit
You may not be if
Left ventricular ejection fraction \<35%
Diameter LA\> 60 mm on transthoracic echocardiography in the "M" -Mode or volume of LA more than 140 ml
Significant regurgitation at the mitral valve
Uncorrected congenital heart disease
RFA PVI, RFA GP, PADN in history
Foregoing heart surgery
Life expectancy less than 12 months
WHO group I, III, IV, V pulmonary artery hypertension
Clareo Health | Safety Procedure Pulmonary Artery Denervation in Addition to Pulmonary Vein Isolation Combined With Ganglionated Plexi Ablation in Patients With Persistent Atrial Fibrillation and Pulmonary Hypertension
